Related Experiment Video
Updated: Aug 9, 2026

10:50
Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding
Published on: September 15, 2010
Structural features of HIV envelope defined by antibody escape mutant analysis
S D'Costa1, K S Slobod, R G Webster
1Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
AIDS Research and Human Retroviruses
|August 28, 2001
Summary
Researchers studied HIV escape variants to understand immune evasion. A new model suggests the V3 loop shields conserved viral regions, aiding HIV immune defense.
Area of Science:
- Virology
- Immunology
- Structural Biology
Background:
- The human immunodeficiency virus (HIV) envelope protein, gp120, is a key target for neutralizing antibodies.
- The V3 loop of gp120 is a major determinant of neutralization sensitivity and a frequent target for antibody escape.
Purpose of the Study:
- To investigate the mechanisms of immune escape from V3-specific neutralizing antibodies.
- To elucidate the structural basis of HIV envelope folding and its implications for viral immune evasion.
Main Methods:
- Generation of HIV-1 (HXB2) escape variants using V3-specific neutralizing antibodies.
- Full gp120 sequencing of escape variants to identify mutations conferring resistance.
- Analysis of sequence data in conjunction with existing crystallographic data.
Main Results:
- Most escape variants acquired mutations within the V3 loop, as expected.
- One variant exhibited escape mutations exclusively in the conserved C2 region, distinct from the V3 loop.
- These findings challenge existing models of gp120 structure and antibody interactions.
Conclusions:
- A novel three-dimensional model of HIV envelope folding is proposed, where the V3 loop interacts with discontinuous C2 residues.
- This proposed structure suggests a mechanism where variable V3 loop residues shield conserved, functionally important regions of gp120.
- This shielding may represent a significant viral immune defense strategy against antibody neutralization.

